George Umemoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
George Umemoto has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
Yoshio Tsuboi
10 shared publicationsShinsuke Fujioka
9 shared publicationsYuriko Dotsu
6 shared publicationsHajime Arahata
NHO Omuta National Hospital
5 shared publicationsHirokazu Furuya
Department of Neurology, Faculty of Medicine, Kochi University, Kochi, Japan
4 shared publicationsNaokazu Sasagasako
4 shared publications
Latest Publications
- 28 September 2026
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 152
Tonic-dominant sleep bruxism in multiple system atrophy: A polysomnographic comparison with Parkinsonian-related disorders
- 28 September 2026
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 152
Tonic-dominant sleep bruxism in multiple system atrophy: A polysomnographic comparison with Parkinsonian-related disorders
- Open Access
- 5 August 2026
- Published by SAGE Publications in Journal of Neuromuscular Diseases
Total energy expenditure assessed by doubly labeled water in patients with myotonic dystrophy type 1: Associations with body composition and functional status
Background & Aims: Myotonic dystrophy type 1 (DM1) is frequently associated with metabolic abnormalities and altered body composition, yet energy metabolism under free-living conditions remains incompletely characterized. This study aimed to characterize total energy expenditure (TEE) using the doubly labeled water (DLW) method and to examine its associations with body composition and functional status. Estimated energy balance was also explored as a secondary variable. Methods: Twelve patients with genetically confirmed DM1 were included. TEE was assessed using the DLW method. Body composition was evaluated using multifrequency bioelectrical impedance analysis. Energy intake was estimated from dietary records, and energy balance was calculated as energy intake minus TEE. Associations were examined using correlation analyses. Results: The mean TEE was 990 ± 169 kcal/day. TEE showed moderate positive associations with skeletal muscle mass and fat-free mass, and functional status was moderately associated with body weight–adjusted TEE. The mean energy intake was 1,355 ± 229 kcal/day, resulting in a positive energy balance of 366 ± 282 kcal/day; however, energy balance was not associated with body fat percentage or fat mass. Conclusions: DLW-measured free-living TEE was markedly low in DM1 patients with severe mobility limitation and reduced lean body mass despite largely normal BMI values. Estimated energy balance was not associated with adiposity. These findings suggest that functional severity and body composition should be considered when interpreting energy expenditure in DM1.
- 5 August 2026
- Published by SAGE Publications in Journal of Neuromuscular Diseases
Open AccessTotal energy expenditure assessed by doubly labeled water in patients with myotonic dystrophy type 1: Associations with body composition and functional status
Background & Aims: Myotonic dystrophy type 1 (DM1) is frequently associated with metabolic abnormalities and altered body composition, yet energy metabolism under free-living conditions remains incompletely characterized. This study aimed to characterize total energy expenditure (TEE) using the doubly labeled water (DLW) method and to examine its associations with body composition and functional status. Estimated energy balance was also explored as a secondary variable. Methods: Twelve patients with genetically confirmed DM1 were included. TEE was assessed using the DLW method. Body composition was evaluated using multifrequency bioelectrical impedance analysis. Energy intake was estimated from dietary records, and energy balance was calculated as energy intake minus TEE. Associations were examined using correlation analyses. Results: The mean TEE was 990 ± 169 kcal/day. TEE showed moderate positive associations with skeletal muscle mass and fat-free mass, and functional status was moderately associated with body weight–adjusted TEE. The mean energy intake was 1,355 ± 229 kcal/day, resulting in a positive energy balance of 366 ± 282 kcal/day; however, energy balance was not associated with body fat percentage or fat mass. Conclusions: DLW-measured free-living TEE was markedly low in DM1 patients with severe mobility limitation and reduced lean body mass despite largely normal BMI values. Estimated energy balance was not associated with adiposity. These findings suggest that functional severity and body composition should be considered when interpreting energy expenditure in DM1.
- Open Access
- 14 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
The relationship between sleep bruxism and sleep-related respiratory events under oral appliance therapy in patients with obstructive sleep apnea
Sleep bruxism (SB), which is frequently observed in patients with obstructive sleep apnea (OSA), has received increasing attention in recent years. Oral appliance (OA) therapy may indirectly influence SB by reducing respiratory events and respiratory-related arousals. This exploratory within-subject study aimed to investigate how OA therapy influences SB activity and arousal characteristics by examining changes in SB, respiratory events, and arousal indices before and after OA therapy in patients with OSA. Patients diagnosed with OSA based on polysomnography (PSG) were referred for OA therapy using a custom-made mandibular advancement OA (monoblock or twin-block design). Twenty-three participants (10 males, 13 females; mean age 58.5 ± 15.8 years) were enrolled. Masseter muscle activity was simultaneously recorded using an identical single-channel wearable electromyography device during PSG. Participants underwent a second PSG and electromyography (EMG) evaluation after OA therapy. Treatment effectiveness was defined as a ≥ 50% reduction in the apnea–hypopnea index (AHI) or a post-treatment AHI < 5. At baseline, the mean AHI was 17.4 [12.4–18.4] events/h, with a mean SB frequency of 13.25 [11.26–23.81] episodes/h. Baseline and post-treatment PSG and EMG evaluations demonstrated a significant reduction in the AHI (p = 0.002) and total SB episodes (p < 0.001), along with a significant increase in spontaneous arousal index (SAI) during the rapid eye movement (REM) stage (p = 0.02). Reductions in total SB episodes were observed in both treatment-response groups; however, SB changes were not consistently aligned with improvements in respiratory indices. The effective group exhibited a significant increase in arousal index (ArI) during REM sleep (p = 0.018) and a significant decrease in respiratory arousal index (RAI) during REM sleep (p = 0.045). These findings suggest that changes in SB under OA therapy are not solely dependent on respiratory improvement and may reflect multifactorial mechanisms. OA therapy may therefore influence SB through both indirect respiratory effects and direct mechanical or neurophysiological pathways.
- 14 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessThe relationship between sleep bruxism and sleep-related respiratory events under oral appliance therapy in patients with obstructive sleep apnea
Sleep bruxism (SB), which is frequently observed in patients with obstructive sleep apnea (OSA), has received increasing attention in recent years. Oral appliance (OA) therapy may indirectly influence SB by reducing respiratory events and respiratory-related arousals. This exploratory within-subject study aimed to investigate how OA therapy influences SB activity and arousal characteristics by examining changes in SB, respiratory events, and arousal indices before and after OA therapy in patients with OSA. Patients diagnosed with OSA based on polysomnography (PSG) were referred for OA therapy using a custom-made mandibular advancement OA (monoblock or twin-block design). Twenty-three participants (10 males, 13 females; mean age 58.5 ± 15.8 years) were enrolled. Masseter muscle activity was simultaneously recorded using an identical single-channel wearable electromyography device during PSG. Participants underwent a second PSG and electromyography (EMG) evaluation after OA therapy. Treatment effectiveness was defined as a ≥ 50% reduction in the apnea–hypopnea index (AHI) or a post-treatment AHI < 5. At baseline, the mean AHI was 17.4 [12.4–18.4] events/h, with a mean SB frequency of 13.25 [11.26–23.81] episodes/h. Baseline and post-treatment PSG and EMG evaluations demonstrated a significant reduction in the AHI (p = 0.002) and total SB episodes (p < 0.001), along with a significant increase in spontaneous arousal index (SAI) during the rapid eye movement (REM) stage (p = 0.02). Reductions in total SB episodes were observed in both treatment-response groups; however, SB changes were not consistently aligned with improvements in respiratory indices. The effective group exhibited a significant increase in arousal index (ArI) during REM sleep (p = 0.018) and a significant decrease in respiratory arousal index (RAI) during REM sleep (p = 0.045). These findings suggest that changes in SB under OA therapy are not solely dependent on respiratory improvement and may reflect multifactorial mechanisms. OA therapy may therefore influence SB through both indirect respiratory effects and direct mechanical or neurophysiological pathways.
- Open Access
- 2 January 2026
- Published by Wiley in Journal of Oral Rehabilitation
- Vol. 53 (4) , 866-879
Effects of a Standardised Medical–Dental Collaborative Protocol on Acute Stroke Rehabilitation: A Multicentre Prospective Cohort Study
Background: Acute stroke often causes complications such as aspiration pneumonia, which can be prevented through oral hygiene. However, evidence supporting individualised oral care remains limited. We developed a multidisciplinary oral function management protocol and evaluated its benefits in patients with acute stroke, including its impact on aspiration pneumonia. Methods: In this prospective multicentre cohort study, data from 1616 patients with acute stroke admitted to participating hospitals between 31 July 2017, and 27 January 2021 were analysed. Hospitals implemented our oral function management program (Protocol group) or provided conventional oral care (control group). To minimise confounding by baseline severity, propensity scores were estimated using stroke severity and initial complications; patients were matched 1:1 using nearest‐neighbour matching with a calliper of 0.2, resulting in 313 matched pairs ( n = 626). Primary outcome was the incidence of aspiration pneumonia; secondary outcomes were hospital stay length and oral function improvement. Results: No significant differences in aspiration pneumonia onset rates were detected between the protocol and control groups ( p = 0.7639). Compared to controls, the protocol group showed significant improvements in oral hygiene ( p < 0.0001), tongue mobility ( p = 0.0292), and FOIS scores ( p = 0.0005). Time from admission to discharge evaluation ( p < 0.0001) and total length of hospital stay ( p = 0.0018) were significantly reduced. Compared to administration of conventional oral care, implementation of this Protocol facilitated earlier oral management and feeding/swallowing rehabilitation, potentially reducing hospital stays and enhancing oral functions. Conclusion: The protocol may enhance oral functionality and reduce hospitalisation duration by systematising multidisciplinary oral management and swallowing rehabilitation, alongside supporting conventional pneumonia prevention strategies.
- 2 January 2026
- Published by Wiley in Journal of Oral Rehabilitation
- Vol. 53 (4) , 866-879
Open AccessEffects of a Standardised Medical–Dental Collaborative Protocol on Acute Stroke Rehabilitation: A Multicentre Prospective Cohort Study
Background: Acute stroke often causes complications such as aspiration pneumonia, which can be prevented through oral hygiene. However, evidence supporting individualised oral care remains limited. We developed a multidisciplinary oral function management protocol and evaluated its benefits in patients with acute stroke, including its impact on aspiration pneumonia. Methods: In this prospective multicentre cohort study, data from 1616 patients with acute stroke admitted to participating hospitals between 31 July 2017, and 27 January 2021 were analysed. Hospitals implemented our oral function management program (Protocol group) or provided conventional oral care (control group). To minimise confounding by baseline severity, propensity scores were estimated using stroke severity and initial complications; patients were matched 1:1 using nearest‐neighbour matching with a calliper of 0.2, resulting in 313 matched pairs ( n = 626). Primary outcome was the incidence of aspiration pneumonia; secondary outcomes were hospital stay length and oral function improvement. Results: No significant differences in aspiration pneumonia onset rates were detected between the protocol and control groups ( p = 0.7639). Compared to controls, the protocol group showed significant improvements in oral hygiene ( p < 0.0001), tongue mobility ( p = 0.0292), and FOIS scores ( p = 0.0005). Time from admission to discharge evaluation ( p < 0.0001) and total length of hospital stay ( p = 0.0018) were significantly reduced. Compared to administration of conventional oral care, implementation of this Protocol facilitated earlier oral management and feeding/swallowing rehabilitation, potentially reducing hospital stays and enhancing oral functions. Conclusion: The protocol may enhance oral functionality and reduce hospitalisation duration by systematising multidisciplinary oral management and swallowing rehabilitation, alongside supporting conventional pneumonia prevention strategies.
- Open Access
- 22 September 2025
- Published by VM Media Group sp. z o.o in Neurologia i Neurochirurgia Polska
- Vol. 59 (5) , 487-490
Association between the degree of Parkinson’s disease progression and the oral environment
Introduction. Aim of this study was to examine the relationship between the degree of Parkinson’s disease (PD) progression and the oral environment in patients with PD. Material and methods. Fifty patients with PD [mean age, 64.9 ± 8.5 years old; mean Hoehn and Yahr (HY) stage, 3.2 ± 0.8] were recruited. The patients were divided into a mild/moderate group (HY stage 2–3) and a severe group (HY stage 4–5), and the oral environment was assessed using the Oral Health Assessment Tool (OHAT) score. Results. The OHAT scores for all participants were positively correlated with the age (rho = 0.27, p < 0.05), disease duration (rho = 0.28, p < 0.05), and MMSE score (rho = –0.28, p < 0.05). Multiple linear regression analyses showed that, among the OHAT items, “tongue,” “saliva,” and “lips” were associated with the age, disease duration, and MMSE, respectively (β = 0.021, p = 0.008; β = 0.027, p = 0.010; β = –1.974, p = 0.041, respectively). Conclusions. The results of this study suggest the possibility of an association between the degree of PD progression, such as age and disease duration, and the deterioration of the oral environment. These results encourage specialized personnel to pay attention to the tongue and dry mouth condition, especially for older PD patients with a long disease duration. Keywords: Parkinson’s disease OHAT disease duration tongue saliva
- 22 September 2025
- Published by VM Media Group sp. z o.o in Neurologia i Neurochirurgia Polska
- Vol. 59 (5) , 487-490
Open AccessAssociation between the degree of Parkinson’s disease progression and the oral environment
Introduction. Aim of this study was to examine the relationship between the degree of Parkinson’s disease (PD) progression and the oral environment in patients with PD. Material and methods. Fifty patients with PD [mean age, 64.9 ± 8.5 years old; mean Hoehn and Yahr (HY) stage, 3.2 ± 0.8] were recruited. The patients were divided into a mild/moderate group (HY stage 2–3) and a severe group (HY stage 4–5), and the oral environment was assessed using the Oral Health Assessment Tool (OHAT) score. Results. The OHAT scores for all participants were positively correlated with the age (rho = 0.27, p < 0.05), disease duration (rho = 0.28, p < 0.05), and MMSE score (rho = –0.28, p < 0.05). Multiple linear regression analyses showed that, among the OHAT items, “tongue,” “saliva,” and “lips” were associated with the age, disease duration, and MMSE, respectively (β = 0.021, p = 0.008; β = 0.027, p = 0.010; β = –1.974, p = 0.041, respectively). Conclusions. The results of this study suggest the possibility of an association between the degree of PD progression, such as age and disease duration, and the deterioration of the oral environment. These results encourage specialized personnel to pay attention to the tongue and dry mouth condition, especially for older PD patients with a long disease duration. Keywords: Parkinson’s disease OHAT disease duration tongue saliva
- 26 December 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 236, 108105
Weight loss in Parkinson's disease: A retrospective comparison between oral medication and device–assisted therapies
- 26 December 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 236, 108105
Weight loss in Parkinson's disease: A retrospective comparison between oral medication and device–assisted therapies
- Open Access
- 13 September 2023
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1259327
Factors that impact dysphagia and discontinuance of oral intake in patients with progressive supranuclear palsy
Objective: To evaluate the swallowing function in the advanced stages of progressive supranuclear palsy (PSP) and clarify the factors that lead to adjustment of food consistency and discontinuation of oral intake.Methods: A total of 56 patients with PSP were recruited. Based on medical records, information about the basic attributes, clinical features (including axial rigidity and dementia), food intake, the results of a videofluoroscopic swallowing study (VFSS), and the timing of nasogastric tube transition and gastrostomy were extracted. From the VFSS images, the presence or absence of aspiration and retrocollis were assessed.Results: The average age at the onset, diagnosis, and the final follow-up examination were 67.6 ± 6.4 years, 71.6 ± 5.8 years, and 75.4 ± 5.6 years, respectively. The average duration of illness was 64.6 ± 42.8 months. Twenty-four individuals (42.9%) were continuing oral intake, while 32 were tube-fed, among whom 16 (50.0%) underwent gastrostomy tube placement. There were significant differences in the duration from the disease onset to tube feeding between the patients with and without cognitive decline at the time of the diagnosis (p < 0.01) and in the duration from the initial VFSS to tube feeding between the patients with and without aspiration on the initial VFSS (p < 0.01). There were significant differences in the duration from the diagnosis to tube feeding and from the initial VFSS to tube feeding between patients with and without axial rigidity at the time of the diagnosis (p < 0.05 and p < 0.05, respectively). Additionally, there was a significant association between axial rigidity and retrocollis (p < 0.01).Conclusion: Cognitive decline, axial rigidity and retrocollis, which are associated with the deterioration of dysphagia in PSP, are the highest risk factors for the discontinuation of oral intake. The early identification of these factors associated with the progression of dysphagia can contribute to the improvement of patient care and management.
- 13 September 2023
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1259327
Open AccessFactors that impact dysphagia and discontinuance of oral intake in patients with progressive supranuclear palsy
Objective: To evaluate the swallowing function in the advanced stages of progressive supranuclear palsy (PSP) and clarify the factors that lead to adjustment of food consistency and discontinuation of oral intake.Methods: A total of 56 patients with PSP were recruited. Based on medical records, information about the basic attributes, clinical features (including axial rigidity and dementia), food intake, the results of a videofluoroscopic swallowing study (VFSS), and the timing of nasogastric tube transition and gastrostomy were extracted. From the VFSS images, the presence or absence of aspiration and retrocollis were assessed.Results: The average age at the onset, diagnosis, and the final follow-up examination were 67.6 ± 6.4 years, 71.6 ± 5.8 years, and 75.4 ± 5.6 years, respectively. The average duration of illness was 64.6 ± 42.8 months. Twenty-four individuals (42.9%) were continuing oral intake, while 32 were tube-fed, among whom 16 (50.0%) underwent gastrostomy tube placement. There were significant differences in the duration from the disease onset to tube feeding between the patients with and without cognitive decline at the time of the diagnosis (p < 0.01) and in the duration from the initial VFSS to tube feeding between the patients with and without aspiration on the initial VFSS (p < 0.01). There were significant differences in the duration from the diagnosis to tube feeding and from the initial VFSS to tube feeding between patients with and without axial rigidity at the time of the diagnosis (p < 0.05 and p < 0.05, respectively). Additionally, there was a significant association between axial rigidity and retrocollis (p < 0.01).Conclusion: Cognitive decline, axial rigidity and retrocollis, which are associated with the deterioration of dysphagia in PSP, are the highest risk factors for the discontinuation of oral intake. The early identification of these factors associated with the progression of dysphagia can contribute to the improvement of patient care and management.
- Open Access
- 7 April 2023
- Published by Springer Nature in Research Square
Impact of Parkinson's disease treatment on fluctuations in weight
Background Weight loss (WL) is the most common symptom among patients with Parkinson's disease (PD) and has been reported to start several years before the diagnosis of PD. The relationship between WL and PD treatment is complex. This study aimed to characterize the impact of PD treatment on WL and find clues to establish the administration of nutrition for patients with PD. Methods Eighty-two patients with PD (mean age, 58.4 ± 10.2 years; mean Hoehn and Yahr stage, 3.2 ± 0.7) were recruited. Their treatments included deep brain stimulation (DBS) therapy (n = 34), levodopa/carbidopa intestinal gel (LCIG) therapy (n = 13), and oral medication alone (n = 35). Based on the medical records, the age of onset, disease duration, treatment options, videofluoroscopic dysphagia scale, blood test results, and weight change were collected. Results The median WL per year and rate of WL were − 1.0 ± 2.8 kg and − 1.9 ± 4.7%, respectively. Most patients (93%) were classified into normal nutrition and mild malnutrition groups by their CONUT scores. The median WL of the DBS group was significantly lower than that of the oral medication alone group (p < 0.01). The rate of WL showed a significant negative correlation with the age of onset (rho = − 0.328, p = 0.003), but showed a significant positive correlation with the disease duration (rho = 0.231, p = 0.04). Conclusions These results highlighted WL in the early stages of PD and suggested the need for adequate monitoring for patients undergoing device-aided therapy as well as oral medicine-treated patients with greater WL.
- 7 April 2023
- Published by Springer Nature in Research Square
Open AccessImpact of Parkinson's disease treatment on fluctuations in weight
Background Weight loss (WL) is the most common symptom among patients with Parkinson's disease (PD) and has been reported to start several years before the diagnosis of PD. The relationship between WL and PD treatment is complex. This study aimed to characterize the impact of PD treatment on WL and find clues to establish the administration of nutrition for patients with PD. Methods Eighty-two patients with PD (mean age, 58.4 ± 10.2 years; mean Hoehn and Yahr stage, 3.2 ± 0.7) were recruited. Their treatments included deep brain stimulation (DBS) therapy (n = 34), levodopa/carbidopa intestinal gel (LCIG) therapy (n = 13), and oral medication alone (n = 35). Based on the medical records, the age of onset, disease duration, treatment options, videofluoroscopic dysphagia scale, blood test results, and weight change were collected. Results The median WL per year and rate of WL were − 1.0 ± 2.8 kg and − 1.9 ± 4.7%, respectively. Most patients (93%) were classified into normal nutrition and mild malnutrition groups by their CONUT scores. The median WL of the DBS group was significantly lower than that of the oral medication alone group (p < 0.01). The rate of WL showed a significant negative correlation with the age of onset (rho = − 0.328, p = 0.003), but showed a significant positive correlation with the disease duration (rho = 0.231, p = 0.04). Conclusions These results highlighted WL in the early stages of PD and suggested the need for adequate monitoring for patients undergoing device-aided therapy as well as oral medicine-treated patients with greater WL.
- Open Access
- 9 December 2022
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 13, 1062134
Relationship between motor dysfunction and chewing movement in patients with Parkinson's disease: A transversal study
Objective: To assess the impact of chewing movement in patients with Parkinson's disease (PD), we examined the relation between chewing movement and motor dysfunction in association with PD progression.Methods: Thirty patients with PD (mean age, 68.9 ± 9.0 years; mean Hoehn and Yahr stage, 3.0 ± 0.7) were recruited. The PD condition was assessed in each patient by using the score of Movement Disorder Society Unified PD Rating Scale (MDS-UPDRS) part III score, body mass index (BMI), serum albumin (Alb), and tongue pressure, number of chews, mealtime, and chewing speed were collected. The patients were divided into two groups (mild and moderate PD groups) based on an MDS-UPDRS part III cut-off value of 32.Results: The chewing speed positively correlated with tongue pressure (rho = 0.69, p < 0.01) in the mild group, and with BMI (rho = 0.54, p = 0.03), serum Alb (rho = 0.63, p = 0.02), and number of chews (rho = 0.69, p < 0.01) in the moderate group. The MDS-UPDRS part III scores for all participants correlated negatively with chewing speed (rho = −0.48, p < 0.01), serum Alb (rho = −0.49, p < 0.01), and positively with mealtime (rho = 0.43, p = 0.01). Tongue pressure and serum Alb were identified to be as factors affecting the chewing speed (β= 0.560, p < 0.01; β= 0.457, p < 0.01, respectively).Conclusions: These results indicated that the progression of motor dysfunction in patients with PD is likely to affect chewing speed and the nutritional status decline may be linked to the impairment of chewing movement in these patients.
- 9 December 2022
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 13, 1062134
Open AccessRelationship between motor dysfunction and chewing movement in patients with Parkinson's disease: A transversal study
Objective: To assess the impact of chewing movement in patients with Parkinson's disease (PD), we examined the relation between chewing movement and motor dysfunction in association with PD progression.Methods: Thirty patients with PD (mean age, 68.9 ± 9.0 years; mean Hoehn and Yahr stage, 3.0 ± 0.7) were recruited. The PD condition was assessed in each patient by using the score of Movement Disorder Society Unified PD Rating Scale (MDS-UPDRS) part III score, body mass index (BMI), serum albumin (Alb), and tongue pressure, number of chews, mealtime, and chewing speed were collected. The patients were divided into two groups (mild and moderate PD groups) based on an MDS-UPDRS part III cut-off value of 32.Results: The chewing speed positively correlated with tongue pressure (rho = 0.69, p < 0.01) in the mild group, and with BMI (rho = 0.54, p = 0.03), serum Alb (rho = 0.63, p = 0.02), and number of chews (rho = 0.69, p < 0.01) in the moderate group. The MDS-UPDRS part III scores for all participants correlated negatively with chewing speed (rho = −0.48, p < 0.01), serum Alb (rho = −0.49, p < 0.01), and positively with mealtime (rho = 0.43, p = 0.01). Tongue pressure and serum Alb were identified to be as factors affecting the chewing speed (β= 0.560, p < 0.01; β= 0.457, p < 0.01, respectively).Conclusions: These results indicated that the progression of motor dysfunction in patients with PD is likely to affect chewing speed and the nutritional status decline may be linked to the impairment of chewing movement in these patients.